Data is not available at this time.
Zuiko Corporation operates in the industrial machinery sector, specializing in the design, development, and manufacturing of converting machines. These machines are critical for producing hygiene products such as diapers, feminine napkins, face masks, and pet care items, serving both domestic and international markets. The company has expanded its portfolio to include used diaper recycling machines and medical equipment, positioning itself as a niche player in sustainable and healthcare-related industrial solutions. With its headquarters in Osaka, Japan, Zuiko leverages decades of expertise since its founding in 1946 to maintain a competitive edge in precision machinery. Its diversified product range caters to growing global demand for hygiene and medical products, reinforcing its market presence amid increasing environmental and health awareness. The company’s focus on innovation and sustainability aligns with broader industry trends, though it faces competition from larger industrial machinery firms.
Zuiko reported revenue of JPY 19.95 billion for the fiscal year ending February 2025, reflecting its operational scale in the converting machinery market. However, the company recorded a net loss of JPY 788 million, with diluted EPS at -JPY 29.78, indicating profitability challenges. Operating cash flow stood at JPY 1.09 billion, suggesting some liquidity despite negative earnings, while capital expenditures of JPY 679 million highlight ongoing investments.
The company’s negative net income and EPS underscore pressures on earnings power, likely due to cost inefficiencies or competitive pricing. Operating cash flow remains positive, but the gap between earnings and cash generation warrants scrutiny. Zuiko’s capital efficiency is tempered by its loss-making position, though its cash reserves of JPY 15.32 billion provide a buffer for strategic adjustments.
Zuiko maintains a strong liquidity position with JPY 15.32 billion in cash and equivalents, offsetting its JPY 7.57 billion total debt. The balance sheet reflects a conservative leverage profile, supported by substantial cash holdings. However, the net loss raises questions about sustainable profitability and the need for operational restructuring to improve financial health over the medium term.
Despite recent losses, Zuiko continues to pay a dividend of JPY 10 per share, signaling management’s commitment to shareholder returns. Growth prospects hinge on demand for hygiene and medical machinery, particularly in international markets. The company’s expansion into recycling and medical systems could drive future revenue, but profitability recovery remains a critical hurdle.
With a market cap of JPY 25.46 billion and a beta of 0.664, Zuiko is viewed as a relatively stable but niche industrial player. The negative earnings and modest dividend yield suggest muted market expectations, though its cash-rich balance sheet may attract value-oriented investors awaiting a turnaround.
Zuiko’s specialized machinery and sustainability-focused innovations provide strategic differentiation. The outlook depends on its ability to capitalize on global hygiene trends and improve cost management. Near-term challenges persist, but long-term potential exists if the company can align profitability with its technological and market strengths.
Company filings, Bloomberg
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |